Short answer
PROCEPT BioRobotics Corp (PRCT) filed an 8-K current report with the SEC on March 6, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Board expanded from 8 to 9 members; Daniel Puckett appointed Class III director, term expires at 2027 annual meeting.
PROCEPT BioRobotics Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expanded from 8 to 9 members; Daniel Puckett appointed Class III director, term expires at 2027 annual meeting
- Puckett brings strong medtech CFO pedigree: ex-CFO of Shockwave Medical (2016–2024) through its ~$13B J&J acquisition
- Also placed on Audit Committee immediately: signals focus on financial oversight and credibility with institutional investors
- Compensation follows standard non-employee director program per April 2025 proxy; no special arrangements disclosed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PROCEPT BioRobotics Corp 8-K filings
Get the next PRCT 8-K as it lands
Follow PRCT for push alerts, or ask the research agent what this filing means.